KIR3DL1 and viral infectious disease: In cases where HLA-A/B is the cognate-ligand for inhibitory KIR, SARS-CoV-2 ORF8-mediated downregulation of HLA-I ligands may actually enhance NK-cell control but evade CTL killing of viral infection.